ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $62,000 | -89.9% | 10,272 | -87.4% | 0.00% | -90.3% |
| Q3 2019 | $615,000 | +515.0% | 81,372 | +342.5% | 0.03% | +416.7% |
| Q1 2019 | $100,000 | +222.6% | 18,388 | +73.7% | 0.01% | +200.0% |
| Q4 2018 | $31,000 | -91.2% | 10,586 | -75.6% | 0.00% | -87.5% |
| Q3 2018 | $353,000 | +113.9% | 43,360 | +155.6% | 0.02% | +128.6% |
| Q2 2018 | $165,000 | -78.1% | 16,961 | -80.5% | 0.01% | -76.7% |
| Q1 2018 | $754,000 | -7.3% | 86,877 | +33.7% | 0.03% | -16.7% |
| Q4 2017 | $813,000 | -27.5% | 64,998 | -51.5% | 0.04% | -36.8% |
| Q3 2017 | $1,121,000 | – | 134,123 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prentice Capital Management, LP | 390,381 | $1,292,000 | 0.49% |
| ETF MANAGERS GROUP, LLC | 891,025 | $2,949,000 | 0.09% |
| AdvisorShares Investments LLC | 353,009 | $1,168,000 | 0.06% |
| ALGERT GLOBAL LLC | 51,028 | $169,000 | 0.05% |
| Bernardo Wealth Planning LLC | 27,219 | $90,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 31,552 | $104,000 | 0.03% |
| ZEKE CAPITAL ADVISORS, LLC | 49,700 | $165,000 | 0.02% |
| Walleye Capital LLC | 51,554 | $171,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 19,021 | $63,000 | 0.01% |
| J.W. COLE ADVISORS, INC. | 37,064 | $123,000 | 0.01% |